Pyxis Oncology, Inc. · NASDAQ:PYXS
Orbimed Advisors LLC reported a 3.60% stake in Pyxis Oncology, Inc. (Schedule 13G)
Event Sep 30, 2026 · Filed Nov 16, 2026
Orbimed Advisors LLC reported a 3.60% stake in Pyxis Oncology, Inc., 4,348,197 shares, as a passive investor on Sep 30, 2026. Filed Nov 16, 2026 (Schedule 13G).
- Stake
- 3.60%
- Shares
- 4,348,197
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| OrbiMed Advisors LLC | 3.40% | 4,013,720 |
| OrbiMed Capital LLC | 3.60% | 4,348,197 |
Source
Download original · View original at SEC
Related
- Pyxis Oncology, Inc.
- Orbimed Advisors LLC
- Pyxis Oncology, Inc. shareholders
- Schedule 13G · Rtw Investments, LP · Nov 16, 2026
- Schedule 13G/A · Bvf Partners L P · Nov 16, 2026
- Schedule 13G/A · Laurion Capital Management LP · Nov 3, 2026
- Schedule 13G/A · GordonMD Global Investments LP · Oct 9, 2026
- Schedule 13G · Coastlands Capital LP · Oct 5, 2026